These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 4591788

  • 21. DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).
    Plotnikoff NP, Kastin AJ, Anderson MS, Schally AV.
    Life Sci I; 1971 Nov 15; 10(22):1279-83. PubMed ID: 4947365
    [No Abstract] [Full Text] [Related]

  • 22. Release of melanocyte-stimulating hormone (MSH) from incubated in situ posterior pituitary lobe in rats.
    Cyrkowicz A, Traczyk WZ.
    Bull Acad Pol Sci Biol; 1972 Nov 15; 20(5):357-60. PubMed ID: 4537645
    [No Abstract] [Full Text] [Related]

  • 23. Hypothalamic releasing factors and Parkinson disease.
    Chase TN, Woods AC, Lipton MA, Morris CE.
    Arch Neurol; 1974 Jul 15; 31(1):55-6. PubMed ID: 4209275
    [No Abstract] [Full Text] [Related]

  • 24. Inactivation of melanocyte-stimulating hormone release-inhibiting factor by a manganese-stimulated bovine brain aminopeptidase.
    Simmons WH, Brecher AS.
    J Biol Chem; 1973 Aug 25; 248(16):5780-4. PubMed ID: 4353274
    [No Abstract] [Full Text] [Related]

  • 25. Ionic requirements for melanophore-stimulating hormone (MSH) release.
    Bower A, Hadley ME.
    Gen Comp Endocrinol; 1972 Aug 25; 19(1):147-58. PubMed ID: 4625838
    [No Abstract] [Full Text] [Related]

  • 26. Effects of acute and chronic administration of DDT upon pituitary melanocyte-stimulating hormone (MSH) activity.
    Peaslee MH, Goldman M, Milburn SE.
    Comp Gen Pharmacol; 1972 Jun 25; 3(10):191-4. PubMed ID: 4542435
    [No Abstract] [Full Text] [Related]

  • 27. Estrogen influence on the hypothalamic enzymes involved in the formation of melanocyte-stimulating hormone release-inhibiting factor (MSH-R-IF).
    Celis ME, Taleisnik S.
    Proc Soc Exp Biol Med; 1974 Jan 25; 145(1):142-4. PubMed ID: 4591390
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neuroendocrine influences on visual discrimination and reversal learning in the albino and hooded rat.
    Sandman CA, Alexander WD, Kastin AJ.
    Physiol Behav; 1973 Nov 25; 11(5):613-7. PubMed ID: 4583903
    [No Abstract] [Full Text] [Related]

  • 30. The control of melanocyte-stimulating hormone secretion.
    Thody AJ, Shuster S.
    J Endocrinol; 1973 Aug 25; 58(2):XXXV-XXXVI. PubMed ID: 4726331
    [No Abstract] [Full Text] [Related]

  • 31. Release of melanocyte-stimulating hormone (MSH) from the posterior pituitary lobe and from the hypothalamus.
    Cyrkowicz A.
    Acta Physiol Pol; 1974 Aug 25; 25(2):183-5. PubMed ID: 4830716
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Isolation and structure of another hypothalamic peptide possessing MSH-release-inhibiting activity.
    Nair RM, Kastin AJ, Schally AV.
    Biochem Biophys Res Commun; 1972 Jun 28; 47(6):1420-5. PubMed ID: 5040241
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Failure of dopamine to promote spermiation in toads.
    Iturriza FC.
    Gen Comp Endocrinol; 1970 Aug 28; 15(1):180-2. PubMed ID: 4917482
    [No Abstract] [Full Text] [Related]

  • 36. Corticotropin-releasing hormone mediates alpha-melanocyte-stimulating hormone-induced anorexigenic action in goldfish.
    Matsuda K, Kojima K, Shimakura S, Wada K, Maruyama K, Uchiyama M, Kikuyama S, Shioda S.
    Peptides; 2008 Nov 28; 29(11):1930-6. PubMed ID: 18656512
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.